Copegus and Vulvovaginal pruritus - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Copegus?
Copegus has active ingredients of ribavirin. It is used in hepatitis c. Currently, eHealthMe is studying from 15,115 Copegus users.
What is Vulvovaginal Pruritus?
Vulvovaginal pruritus (vulvovaginal severe itching) is found to be associated with 888 drugs and 509 conditions by eHealthMe. Currently, we are studying 5,665 people who have Vulvovaginal pruritus.
Do you take Copegus and have Vulvovaginal pruritus?Check whether Vulvovaginal pruritus is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Copegus side effects by duration, gender and age:
- Copegus side effects (15,115 reports)
Vulvovaginal pruritus treatments and more:
- Vulvovaginal pruritus (5,665 reports)
All the drugs that are associated with Vulvovaginal pruritus:
All the conditions that are associated with Vulvovaginal pruritus:
How the study uses the data?
The study uses data from the FDA. It is based on ribavirin (the active ingredients of Copegus) and Copegus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zestoretic and Actos drug interaction - now
- Seroquel and Malignant Hypertension (Arteriolar Nephrosclerosis) - 2 seconds ago
- Finasteride and Colestipol Hydrochloride drug interaction - 2 seconds ago
- Promethazine W/ Codeine and Fall - 4 seconds ago
- Ziagen and Cellulitis Aggravated - 8 seconds ago
- Pyridium and Theophylline drug interaction - 11 seconds ago
- Flexeril and Pancreatic Disorder - 11 seconds ago
- Genvoya and Intervertebral Disc Degeneration - 23 seconds ago
- Fingolimod and Pruritus Aggravated - 40 seconds ago
- Baraclude and Pulmonary Tuberculosis Aggravated - 40 seconds ago